Literature DB >> 2846758

Evaluation of a monoclonal antibody blocking ELISA for the detection of group-specific antibodies to bluetongue virus in experimental and field sera.

R A Lunt1, J R White, S D Blacksell.   

Abstract

In order to overcome serological cross-reactions among orbivirus serogroups, which can hinder the accurate diagnosis of bluetongue virus (BTV) infection of livestock, a blocking ELISA (B-ELISA) incorporating a monoclonal antibody (20E9B7G2) with specificity for the BTV serogroup was developed. Experimental antisera raised to South African BTV serotypes 1 to 19 were tested in the B-ELISA and all blocked the binding of 20E9B7G2 to BTV antigen. The sensitivity and specificity of the assay was evaluated with a range of experimental and field sera and compared to a sensitive indirect ELISA (I-ELISA) for the detection of BTV-specific antibodies. The specificity of the B-ELISA was absolute for antibodies to BTV, showing no cross-reaction with experimental antisera to serotypes of the closely related orbivirus causing epizootic haemorrhagic disease of deer. The sensitivity of the B-ELISA exceeded that of the I-ELISA. In particular, the B-ELISA detected a BTV-specific antibody response much earlier after infection that the I-ELISA, while still exhibiting full sensitivity to BTV antibody titres several months after infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846758     DOI: 10.1099/0022-1317-69-11-2729

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Topography and immunogenicity of bluetongue virus VP7 epitopes.

Authors:  L F Wang; A D Hyatt; P L Whiteley; M Andrew; J K Li; B T Eaton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus.

Authors:  H S Nagesha; L F Wang; A D Hyatt; C J Morrissy; C Lenghaus; H A Westbury
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  Development and evaluation of an enzyme-linked immunosorbent assay for detection of bovine antibodies to epizootic hemorrhagic disease of deer viruses.

Authors:  A Afshar; P F Wright; L A Taylor; J L Shapiro; G C Dulac
Journal:  Can J Vet Res       Date:  1992-04       Impact factor: 1.310

4.  Seasonal drivers of the epidemiology of arthropod-borne viruses in Australia.

Authors:  Jemma L Geoghegan; Peter J Walker; Jean-Bernard Duchemin; Isabelle Jeanne; Edward C Holmes
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

5.  Seroprevalence of Q Fever, Brucellosis, and Bluetongue in Selected Provinces in Lao People's Democratic Republic.

Authors:  Bounlom Douangngeun; Watthana Theppangna; Vilayvahn Soukvilay; Chanthana Senaphanh; Kamphok Phithacthep; Souk Phomhaksa; Samuel Yingst; Eric Lombardini; Eric Hansson; Paul W Selleck; Stuart D Blacksell
Journal:  Am J Trop Med Hyg       Date:  2016-07-18       Impact factor: 2.345

6.  Standardization and application of real-time polymerase chain reaction for rapid detection of bluetongue virus.

Authors:  I Karthika Lakshmi; Kalyani Putty; Satya Samparna Raut; Sunil R Patil; P P Rao; B Bhagyalakshmi; Y Krishna Jyothi; B Susmitha; Y Vishnuvardhan Reddy; Sowmya Kasulanati; J Shiva Jyothi; Y N Reddy
Journal:  Vet World       Date:  2018-04-10

Review 7.  Diagnosing bluetongue virus in domestic ruminants: current perspectives.

Authors:  José M Rojas; Daniel Rodríguez-Martín; Verónica Martín; Noemí Sevilla
Journal:  Vet Med (Auckl)       Date:  2019-02-14

8.  Quantification of recombinant core-like particles of bluetongue virus using immunosorbent electron microscopy.

Authors:  Y Z Zheng; A Hyatt; L F Wang; B T Eaton; P F Greenfield; S Reid
Journal:  J Virol Methods       Date:  1999-06       Impact factor: 2.014

9.  A single chain Fv antibody displayed on phage surface recognises conformational group-specific epitope of bluetongue virus.

Authors:  H S Nagesha; L F Wang; B Shiell; G Beddome; J R White; R A Irving
Journal:  J Virol Methods       Date:  2001-02       Impact factor: 2.014

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.